Covalon, AVA & Dr. Nancy Moureau Tackle IV Therapy
19 Feb 2026 //
BUSINESSWIRE
Covalon Shows Innovations For Critically Ill Children At APHON
25 Sep 2025 //
BUSINESSWIRE
Covalon Reports Fifth Consecutive Quarter of Positive Earnings
28 May 2025 //
BUSINESSWIRE
Covalon Announces New Clinical Research on VALGuard Guard
27 May 2025 //
BUSINESSWIRE
Covalon to Discuss Q2 Fiscal 2025 Results in Conference Call
21 May 2025 //
BUSINESSWIRE
Covalon Retain Advisor for Shareholder Value-Enhancing Opportunity
20 May 2025 //
BUSINESSWIRE
Covalon Promotes Kim Crooks to COO and Board Member
15 May 2025 //
BUSINESSWIRE
Covalon to Present at 2025 Bloom Burton Healthcare Conf. on May 6
30 Apr 2025 //
BUSINESSWIRE
Covalon to Present at Planet MicroCap Showcase
17 Apr 2025 //
BUSINESSWIRE
Covalon announces fiscal 2024 annual meeting voting results
20 Mar 2025 //
BUSINESSWIRE

Market Place
Sourcing Support